Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
Authors:
- Alfonso Sánchez-MuñozASAlfonso Sánchez-Muñoz
- César MendiolaCMCésar Mendiola
- Elisabeth Pérez-RuizEPElisabeth Pérez-Ruiz
- César A. Rodríguez-SánchezCRCésar A. Rodríguez-Sánchez
- José Miguel JuradoJJJosé Miguel Jurado
- Lorenzo Alonso-CarriónLALorenzo Alonso-Carrión
- Ismael GhanemIGIsmael Ghanem
- Guillermo de VelascoGuillermo de Velasco
- Cristina Quero-BlancoCQCristina Quero-Blanco
- Emilio AlbaEAEmilio Alba
- 15 November 2010
- journal article
- Published by S. Karger AG in Oncology
- Vol. 79 (1-2) , 98-104